Patients with COVID-19 taking molnupiravir or nirmatrelvir-ritonavir rarely have viral rebound, and rebound is not associated with increased mortality risk, according to a study published online Dec.
A new study by investigators from Mass General Brigham found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, ...
Bend, Ore., [Nov. 20, 2020] —Scott Johnson, PT, OCS, CF-L1, has joined the staff of Rebound Physical Therapy’s Bend East Clinic. Scott grew up just outside of Flint, Michigan and received his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results